Skip to main content
Clinical Trials/JPRN-jRCTs031180412
JPRN-jRCTs031180412
Recruiting
未知

The efficacy of H. pylori eradication therapy with sitafloxacin-metronidazole-vonaprazan 10 days regimen

Hirata Kenro0 sites100 target enrollmentMarch 22, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Hirata Kenro
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 22, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hirata Kenro

Eligibility Criteria

Inclusion Criteria

  • H. pylori\-positve patients after the 2nd line H. pylori eradication therapy or penicillin\-allergic patients

Exclusion Criteria

  • 1\. Patients with allergy for quinolones
  • 2\. Patients with allergy for PPIs
  • 3\. Patients with severe liver injury and/or severe renal damage
  • 4\. Pregnancy or possible pregnancy
  • 5\. Patients who were recognized as inappropriate for entry

Outcomes

Primary Outcomes

Not specified

Similar Trials